For example, FK506 is a compound that prevents FKBP12 inhibition of BMPR2 signaling in blood vessels, and the restoration of BMP signaling afforded by the drug ameliorates symptoms in mouse models of PAH [83]. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.